Spots Global Cancer Trial Database for bk virus infection
Every month we try and update this database with for bk virus infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients | NCT05101213 | Adenovirus Infe... BK Virus Infect... Cytomegaloviral... Hematopoietic a... JC Virus Infect... Malignant Solid... Symptomatic COV... | Virus-specific ... | 18 Years - | M.D. Anderson Cancer Center | |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus | NCT02479698 | Acquired Immuno... BK Virus Infect... Human Immunodef... JC Virus Infect... Malignant Neopl... Merkel Cell Car... Merkel Cell Pol... Viral Encephali... | Allogeneic BK-s... Laboratory Biom... | - | M.D. Anderson Cancer Center | |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT05305040 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... Placebo | - | AlloVir | |
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS | NCT05618275 | BK Virus Infect... | 1 Year - 19 Years | University Hospital, Strasbourg, France | ||
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT05305040 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... Placebo | - | AlloVir | |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients | NCT05101213 | Adenovirus Infe... BK Virus Infect... Cytomegaloviral... Hematopoietic a... JC Virus Infect... Malignant Solid... Symptomatic COV... | Virus-specific ... | 18 Years - | M.D. Anderson Cancer Center | |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT04693637 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... | 1 Year - | AlloVir | |
| Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS | NCT05618275 | BK Virus Infect... | 1 Year - 19 Years | University Hospital, Strasbourg, France |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
